STATE STREET CORP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 273 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$119,108,815
-25.3%
1,178,711
+0.6%
0.01%
-12.5%
Q2 2023$159,401,119
+31.5%
1,171,244
+0.5%
0.01%
+14.3%
Q1 2023$121,246,930
-39.7%
1,165,135
-48.5%
0.01%
+16.7%
Q4 2022$201,009,944
+132.1%
2,262,708
+110.0%
0.01%
+20.0%
Q3 2022$86,594,000
-13.8%
1,077,498
+2.9%
0.01%
-16.7%
Q2 2022$100,483,000
-35.3%
1,047,129
+0.4%
0.01%
-25.0%
Q1 2022$155,202,000
+6.8%
1,043,392
+1.9%
0.01%
+14.3%
Q4 2021$145,353,000
+7.4%
1,023,875
-0.8%
0.01%0.0%
Q3 2021$135,299,000
-3.1%
1,032,577
+1.8%
0.01%0.0%
Q2 2021$139,591,000
+9.4%
1,014,247
+4.0%
0.01%0.0%
Q1 2021$127,604,000
+17.0%
975,614
+0.3%
0.01%0.0%
Q4 2020$109,101,000
+46.2%
972,436
+2.8%
0.01%
+40.0%
Q3 2020$74,617,000
+5.2%
946,027
-3.7%
0.01%0.0%
Q2 2020$70,913,000
+30.2%
982,399
+3.7%
0.01%0.0%
Q1 2020$54,444,000
-46.2%
947,386
+4.9%
0.01%
-28.6%
Q4 2019$101,225,000
+15.1%
903,517
-1.0%
0.01%0.0%
Q3 2019$87,945,000
+0.8%
912,766
-10.3%
0.01%0.0%
Q2 2019$87,274,000
+4.8%
1,017,594
+1.9%
0.01%
+16.7%
Q1 2019$83,259,000
+29.4%
998,514
-0.1%
0.01%0.0%
Q4 2018$64,358,000
-22.7%
999,519
-4.8%
0.01%0.0%
Q3 2018$83,217,000
+18.7%
1,050,103
+9.7%
0.01%0.0%
Q2 2018$70,121,000
+46.7%
957,586
+26.9%
0.01%
+50.0%
Q1 2018$47,797,000
+5.0%
754,705
-15.4%
0.00%0.0%
Q4 2017$45,521,000
+23.8%
892,466
+27.3%
0.00%
+33.3%
Q3 2017$36,768,000
+2.9%
700,799
-0.0%
0.00%0.0%
Q2 2017$35,715,000
+18.6%
701,058
+3.4%
0.00%0.0%
Q1 2017$30,120,000
+8.1%
678,139
+7.5%
0.00%0.0%
Q4 2016$27,875,000
+17.7%
630,996
+6.7%
0.00%
+50.0%
Q3 2016$23,678,000
-11.7%
591,117
+5.2%
0.00%
-33.3%
Q2 2016$26,823,000
+14.6%
562,027
+0.7%
0.00%0.0%
Q1 2016$23,415,000
-9.2%
558,315
-4.6%
0.00%0.0%
Q4 2015$25,782,000
-5.1%
585,320
+2.9%
0.00%0.0%
Q3 2015$27,157,000
-19.7%
568,855
-2.0%
0.00%
-25.0%
Q2 2015$33,836,000
+9.4%
580,664
-5.2%
0.00%
+33.3%
Q1 2015$30,932,000
+12.2%
612,574
-0.1%
0.00%0.0%
Q4 2014$27,566,000
+21.8%
613,205
-0.2%
0.00%
+50.0%
Q3 2014$22,628,000
-18.9%
614,214
-2.8%
0.00%
-33.3%
Q2 2014$27,905,000
-2.9%
632,033
-4.4%
0.00%0.0%
Q1 2014$28,738,000
-36.9%
661,390
-48.6%
0.00%0.0%
Q4 2013$45,551,000
+97.8%
1,286,698
+89.9%
0.00%0.0%
Q3 2013$23,027,000
+8.1%
677,509
-0.7%
0.00%0.0%
Q2 2013$21,305,000682,0150.00%
Other shareholders
CONMED CORP shareholders Q3 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders